Gateway Investment Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $248K | Sell |
|
|||||
|
2024
Q4 | $297K | Buy |
|
|||||
|
2024
Q3 | $313K | Sell |
|
|||||
|
2024
Q2 | $1.04M | Sell |
|
|||||
|
2024
Q1 | $1.86M | Buy |
|
|||||
|
2023
Q4 | $1.24M | Hold |
|
|||||
|
2023
Q3 | $1.14M | Sell |
|
|||||
|
2023
Q2 | $1.13M | Sell |
|
|||||
|
2023
Q1 | $3.63M | Sell |
|
|||||
|
2022
Q4 | $3.9M | Sell |
|
|||||
|
2022
Q3 | $3.2M | Buy |
|
|||||
|
2022
Q2 | $3.13M | Buy |
|
|||||
|
2022
Q1 | $2.82M | Buy |
|
|||||
|
2021
Q4 | $901K | Buy |
|
|||||
|
2021
Q3 | $773K | Sell |
|
|||||
|
2021
Q2 | $839K | Sell |
|
|||||
|
2021
Q1 | $768K | Sell |
|
|||||
|
2020
Q4 | $906K | Buy |
|
|||||
|
2020
Q3 | $784K | Sell |
|
|||||
|
2020
Q2 | $1.28M | Sell |
|
|||||
|
2020
Q1 | $883K | Sell |
|
|||||
|
2019
Q4 | $1.16M | Sell |
|
|||||
|
2019
Q3 | $1.32M | Sell |
|
|||||
|
2019
Q2 | $1.68M | Sell |
|
|||||
|
2019
Q1 | $1.75M | Buy |
|
|||||
|
2018
Q4 | $1.67M | Buy |
|
|||||
|
2018
Q3 | $1.34M | Sell |
|
|||||
|
2018
Q2 | $1.31M | Sell |
|
|||||
|
2018
Q1 | $1.13M | Buy |
|
|||||
|
2017
Q4 | $863K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $274K | Buy |
|